Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers
Go back to Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers| (NASDAQ: PGEN) | Delayed: 6.87 -0.23 (3.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.10 | 52 Week High | $ | |||
| Open | $6.89 | 52 Week Low | $ | |||
| Day High | $7.02 | P/E | N/A | |||
| Day Low | $6.72 | EPS | $ | |||
| Volume | 2,770,580 | |||||

